Popular Articles

Cardica Announces Publication Of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
Cardica, Inc. (Nasdaq: CRDC) announced that the full results of the PAS-Port system multi-center pivotal trial, known as the EPIC trial, were published in the July issue of the peer-reviewed publication The Journal of Thoracic and Cardiovascular Surgery. The PAS-Port system, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in September 2008, creates a secure connection, or anastomosis, between a vein graft and the aorta, the main artery in the human body, during coronary artery bypass grafting (CABG) procedures.

Gene Theory For Depression Is Now Discredited
A study that attempted to replicate the "seminal" study that laid the
News of the day
Obama Names Alabama Family Physician Benjamin To Be Surgeon General
President Obama on Monday nominated Alabama family physician Regina Benjamin, founder of the Bayou La Batre Rural Health Clinic, to be the U.S. surgeon general, the AP/Detroit Free Press reports (Neergaard, AP/Detroit Free Press, 7/13). Benjamin"s clinic serves a low-income community of about 2,500 and has earned a national reputation treating all patients, regardless of their ability to pay. Benjamin founded the clinic in 1990 and repeatedly rebuilt it after two hurricanes and a fire (Zhang, Wall Street Journal, 7/14). In 2008, she received one of the MacArthur Foundation"s $500,000 "genius grants" (Lloyd, USA Today, 7/14). In 1995, Benjamin became the first black woman to be elected to the American Medical Association Board of Trustees. Benjamin also has served as associate dean for rural health at the University of South Alabama College of Medicine (Bellantoni, Washington Times, 7/13). In 2002, she became president of the Medical Association of the State of Alabama, making her the first black woman to be president of a state medical society (Mostrous/Shear, Washington Post, 7/14).Benjamin is a "devout Roman Catholic," according to the New York Times. The administration did not disclose her views on abortion. Benjamin routinely prescribes oral contraceptives, but the clinic does not have the facilities to perform abortions, according to nurse Audrey Bosarge, a colleague of Benjamin"s (Harris, New York Times, 7/14). In his announcement, Obama said Benjamin understands the needs of the low-income and uninsured U.S. residents, which makes her uniquely qualified to serve as surgeon general during health care overhaul negotiations (Wall Street Journal, 7/14). In accepting the nomination, Benjamin vowed to ensure that "no one falls through the cracks as we improve our health care system." Benjamin"s nomination requires Senate confirmation (AP/Detroit Free Press, 7/13).
Health Insurance

Unisense FertiliTech A/S Receives CE Mark Of Approval For EmbryoScope(TM) Embryo Monitoring System

Unisense FertiliTech A/S announces that the EmbryoScope(TM) Embryo Monitoring System and EmbryoSlide(TM) tray have received CE approval as class IIa medical devices for use in IVF. Unisense Fertilitech A/S also received the DS/EN ISO13485:2003 and AC:2007 quality system certificate for production, installation and servicing of IVF incubators and related accessories. Francesca Bahr, sales manager at Unisense FertiliTech A/S says, "the CE mark will allow us to market the instrument to Assisted Reproduction clinics across Europe, with the goal of improving embryo assessment and to facilitate the goal of elective single embryo transfer." During IVF treatment, multiple oocytes are removed from the patient and fertilized in-vitro. The resulting fertilized eggs are cultured for a period of 2 to 5 days, before the embryologist must select the best potential embryo or embryos to transfer to the patient. Ideally, a single embryo resulting in a single pregnancy is optimal as multiple pregnancies present risks to maternal and fetal health. A major challenge for the embryologist is determining which embryos have the best potential to create a single healthy baby. The EmbryoScope(TM) Monitoring System allows uninterrupted observation of embryo development in a stable environment. Embryo quality parameters can be assessed and reviewed without the potentially damaging effects of removing the embryo from a controlled incubation environment. Retrospective analysis of development will allow embryologists to identify potentially new parameters for embryo analysis. Mette Munch, Director of regulatory affairs at Unisense FertiliTech A/S says she will now set her goal on FDA 510K clearance in order to facilitate marketing to clinics in the United States. The Announcement of the CE mark coincided with the successful sales launch of the EmbryoScope(TM) Embryo Monitoring System at the European society of Human reproduction and Embryology in Amsterdam, June 29.July 1 2009 Unisense Fertilitech A/S is a Danish company which was founded in 2003, as a daughter company of Unisense A/S. The company develops and manufactures instruments and analysis solutions to facilitate in-vitro Fertilization. The company is currently involved in various international research projects involving embryo selection and analysis, embryo respiration and stem cell research. Unisense FertiliTech A/S


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):